A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma

Clinical trial NCT01790503 · COMPLETED

Trial details

NCT number: NCT01790503
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Patients With Newly Diagnosed Glioblastoma

Start date: 2013-07-18
Primary completion: 2017-11-03
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.